Recovery of Exertion Ability Following COVID-19 Infection in Military Staff (CovEx)
The Paris Fire Brigade staff have been particularly exposed to COVID-19 due to rescue and care activities for victims at risk in Paris area (where the virus was actively circulating). In addition, when the pandemic began in France, they had to take care of patients before procedures to protect caregivers were implemented.
The contamination of young military personnel, whose physical capacity was put into strain at work, raises the question of the consequences of COVID-19 on their physical fitness. At the time, the medium- and long-term evolution of this disease and its possible repercussions on physical fitness are unknown. Moreover, like any soldiers who have been confined, they may present at least a cardio-respiratory deconditioning (sometimes independent of the disease making it difficult to distinguish between a sequelae of the infection or rehabilitation).
Based on previous coronavirus epidemics (Sars-Cov 1 and Mers-Cov), it appears that long-term sequelae are possible even in mild forms and can result in an alteration of exertion ability.
In the current context and in the absence of national or international recommendations on the return to physical activity, the French Armed Forces Health Service has proposed a simple management plan aiming at: i) allowing mass screening for possible exercise intolerance and targeting at-risk personnel, ii) allowing individualized re-training and iii) guaranteeing that military personnel can carry out their mission without jeopardizing their health.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiekontakt
- Navn: Alexandra MALGOYRE, MD, PhD
- Telefonnummer: +33 169631317
- E-mail: alexandra.malgoyre@intradef.gouv.fr
Studiesteder
-
-
-
Brétigny-sur-Orge, Frankrig, 91223
- Rekruttering
- Institut de Recherche Biomédicale des Armées
-
Kontakt:
- Alexandra MALGOYRE, MD, PhD
- Telefonnummer: +33 169631317
- E-mail: alexandra.malgoyre@intradef.gouv.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Be an active military personnel of the Paris Fire Brigade
- Be at least 18 years of age
- Benefiting or having benefited from the post-COVID medical care provided by the French Armed Forces Health Service
Exclusion Criteria:
- Be under 18 years of age
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Magnitude of the decrease in aerobic performance on return to work
Tidsramme: Up to 18 months
|
Aerobic performance will be assessed through a test called VAMEVAL.
VAMEVAL consists of running around a track marked out every 50 meters to the rhythm of a soundtrack that accelerates at a rate of 0.5 km/h in 2-minute increments until exhaustion or inability to maintain the pace of the race.
The result of the test made on return to work will be compared to the last result on the same test performed before COVID-19 infection.
|
Up to 18 months
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2020-COVID19-30
- 2020-A02140-39 (Anden identifikator: IDRCB)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med SARS-CoV-infektion
-
Chengdu Kangnuoxing Biopharma,Inc.Ikke rekrutterer endnu
-
IRCCS San RaffaeleAfsluttetAntistofrespons | Cellulær immunrespons | SAR-CoV-2Italien
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR); Health CanadaIkke rekrutterer endnuInfluenza A | Influenza B | Akutte luftvejsinfektioner (ARI'er) | SAR-CoV-2Canada
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS)Afsluttet
-
Jianfeng XieRekrutteringCLABSI - Central Line Associated Bloodstream InfectionKina
-
Fondazione Policlinico Universitario Agostino Gemelli...Lo.Li.Pharma s.r.lIkke rekrutterer endnuHPV - Anogenital Human Papilloma Virus Infection | Infertilitet
-
Shanghai PerHum Therapeutics Co., Ltd.Shanghai Zhongshan HospitalAfsluttet
-
Emory UniversityCenters for Disease Control and PreventionAfsluttetHospitalsinfektion | Standardiseret Antibiotika-Ordinationsratio (SAR)Forenede Stater
-
Chengdu Kangnuoxing Biopharma,Inc.Ikke rekrutterer endnuSæsonbestemt allergisk rhinitis (SAR)Kina
-
University of Santiago de CompostelaOsteology FoundationRekruttering